Actemra 400 mg/20 mL injection Images
Generic Name: tocilizumab
This medication has been identified as Actemra 400 mg/20 mL injection. It is supplied by Genentech, Inc.
Actemra is used in the treatment of Giant Cell Arteritis; Rheumatoid Arthritis; COVID-19; Cytokine Release Syndrome; Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 400 mg/20 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Actemra
- Generic Name
- tocilizumab
- Strength
- 400 mg/20 mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0137
See also:
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Sterapred
Sterapred is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Tofidence
Tofidence (tocilizumab-bavi) is administered as an intravenous infusion by a healthcare provider ...
Upadacitinib
Upadacitinib is an oral Janus kinase (JAK) inhibitor that may be used alone or in combination with ...
Prednisone
Prednisone is used to treat allergic disorders, ulcerative colitis, psoriasis and arthritis. Learn ...
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (49)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.